Back to Conference Homepage
Back to Conference Faculty List
Back to Conference Schedule
CLICK HERE to see the PowerPoint Presentation
Time: Friday Morning
Purpose: To better understand the racial disparities in the presentation, treatment, and outcomes of women diagnosed with gynecologic malignancies
Objectives:
Review areas of consensus and controversy in the treatment of ovarian cancers based on results of recent randomized controlled clinical trials
Identify novel biologic therapeutic agents for ovarian cancer
Evaluate the advances in minimally invasive surgery in uterine cancer
Discuss the efficacy of HPV vaccine in prevention of cervical cancer
Current Positions:
Assistant Professor, Obstetrics, Gynecology, & Reproductive Sciences, UCSF
Director of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center
Bio:
Dr. John K. Chan is the Director of the Division of Gynecologic Oncology and Associate Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco. He currently holds the John A. Kerner Distinguished Professorship in Gynecologic Oncology. Dr. Chan received his Medical Degree from the University of California, Los Angeles, followed by Residency in Obstetrics and Gynecology at the University of California, Irvine and Fellowship in Gynecologic Oncology at the University of California, Irvine and the MD Anderson Cancer Center.
His research focuses on developing new therapies for gynecologic cancers, including genomic therapy and targeted biologic therapies, as well as investigating the role of tumor-initiating cells in ovarian cancer. He is involved in outcomes-based studies examining the treatment and outcomes of ovarian and uterine cancer patients. Dr. Chan has also recently been appointed as the principal investigator for one of the largest advanced ovarian cancer clinical trials in the country, which is currently under development at the National Cancer Institute. He has received research funding from the National Institutes of Health and the Institute of Aging to study the effects of prophylactic surgery on ovarian cancer risk.
Dr. Chan is an active member of the Gynecologic Oncology Group Ovarian Cancer Committee and has been elected as the study chair for three Gynecologic Oncology Group protocols. He has received numerous grants and awards, including those from the National Cancer Institute, the Ovarian Cancer Research Foundation, and the Gynecologic Oncology Group.
Dr. Chan was selected as a member of the Scientific Program Committee for the Society of Gynecologic Oncologists and has played a major role in organizing educational programs for national and international gynecologic cancer societies. He is an active member in numerous academic organizations including the American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncologists. Dr. Chan has authored and co-authored nearly 100 manuscripts in journals including Gynecologic Oncology, Cancer, Obstetrics & Gynecology, Journal of Clinical Oncology, British Journal of Cancer, American Journal of Obstetrics and Gynecology, Lancet Oncology, Cancer Research, and Clinical Cancer Research. He is also the co-author of three textbooks in the field of Gynecologic Oncology.
More Info